FMI opines the microneedle patch influenza vaccine delivery market was valued at USD 19.5 million in 2025. The industry is expected to reach USD 24.0 million in 2026 and USD 190.2 million by 2036. High-density coated microarray patches are poised to lead by Patch technology with 34.8% share in 2026, and Seasonal inactivated influenza vaccines are expected to dominate by Vaccine format through the forecast period.